Last updated: 2026-10-13 03:48:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
NewGenIvf Group Limited (NIVF) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.24, with a market capitalization of $492.08K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.12 to $6,156.00. This page covers its latest market performance, valuation, price trends and company information.
$492.08K | |
$0.28 | |
$7,084,800.00 | |
$0.12 | |
$0.29 | |
1.73M | |
6.17M | |
-- | |
$6,156.00 | |
$0.12 | |
-- | |
-- |
NewGenIvf Group Limited (NIVF) last closed at $0.29 as of 2026-10-13 00:00:00, unchanged from the previous close of $0.29.
During the latest regular trading session, NIVF traded between $0.12 and $7,084,800.00, with a volume of 1.73M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, NewGenIvf Group Limited (NIVF) moved from $0.40 to $0.24, representing a decline of 40.84% ($0.17).
The stock traded between $0.12 and $0.65 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 21.65 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.0%
NIVF is currently trading at $0.24, placing it 0.0% of the way from its 52-week low of $0.12 to its 52-week high of $6,156.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NewGenIvf Group Limited (NIVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.